Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel(Breakthrough T1D), Anette‐G. Ziegler(TUM Klinikum), Jay S. Skyler(University of Miami), Jessica L. Dunne(Sanofi (United States)), Jane L. Chiang(American Diabetes Association), Kevan C. Herold(Yale University), Desmond Schatz(University of Florida), Åke Lernmark(Lund University), Marian Rewers(University of Colorado Denver), Mark A. Atkinson(University of Florida), Robert E. Ratner(W.K. Kellogg Foundation), Peter A. Gottlieb(University of Colorado Health), Jeffrey P. Krischer(University of South Florida), Dana Dabelea(Colorado School of Public Health), Jay M. Sosenko(University of Miami), Carla J. Greenbaum(Society of Interventional Radiology)
Cited by 1,178
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k